chartexchange

RNXT
RenovoRx, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:21:16 PM EST
1.04USD-7.143%(-0.08)222,754
Pre-marketNov 19, 2026 9:24:30 AM EST
1.16USD+3.571%(+0.04)
1.0400Bid1.0600Ask0.0200Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Los Altos, CA, USA
Previous Close
$1.12
Beta
1.55
52-Week High
$2.59 2026-09-02
52-Week Low
$0.73 2025-11-19
SMA 50
$1.38
SMA 200
$1.11
Avg. Vol 10D
699,850
Avg. Vol 30D
478,082
Avg. Vol 90D
692,825
Relative Vol
0.46
46.48M
1.5400%
1,600,000
770
RNXT Profile

renovorx is a medical device company headquartered in silicon valley, california. we are developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. the ability to deliver these materials at high concentration to specific vasculature, safely and without perfusion overlap to other regions, is a central paradigm of our technology. we have received fda clearance for the renovocath™ rc120 and are now introducing our innovative technology to the clinical market. renovorx is a highly motivated team with broad experience and an exciting vision for the future of targeted delivery. we are backed by a broad medical advisory board and a strong board of directors. please contact us at info@renovorx.com to learn more.

RNXT Performance
PeriodPriceDateChangeBeta
1W1.162026-11-12-10.35%3.739
1M1.162026-10-19-10.35%2.224
3M1.322026-08-19-20.91%2.210
6M0.812026-05-19+29.05%2.206
1Y0.732025-11-19+41.98%1.553
2Y1.112024-11-19-6.31%—
5Y6.592021-11-19-84.22%0.954
RNXT Stock Summary

RenovoRx, Inc. Common Stock (NASDAQ:RNXT) stock price today is $1.04, and today's volume is 220,572. RNXT is down 7.143% today. The 30 day average volume is 478,082. RNXT market cap is $50.18M with 48.25M shares outstanding.